Theralase Technologies Inc. (TLT) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.125x

Based on the latest financial reports, Theralase Technologies Inc. (TLT) has a cash flow conversion efficiency ratio of -0.125x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-244.54K ≈ $-176.90K USD) by net assets (CA$1.95 Million ≈ $1.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TLT net asset quality index to measure how much of total assets are equity-financed.

Theralase Technologies Inc. - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Theralase Technologies Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Theralase Technologies Inc. cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Theralase Technologies Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Theralase Technologies Inc. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Great Computer
TWO:8047
0.057x
China Fineblanking Technology Co Ltd
TWO:1586
0.013x
Dae Chang
KO:012800
-0.035x
SERESCO (ACC.P.DESD.)-16
F:XV7
N/A
Gemfields Group Ltd
JSE:GML
0.053x
Chemfab Alkalis Limited
NSE:CHEMFAB
0.030x
Nice D&B Co. Ltd
KQ:130580
0.023x
Multifiling Mitra Indonesia
JK:MFMI
0.602x

Annual Cash Flow Conversion Efficiency for Theralase Technologies Inc. (2001–2025)

The table below shows the annual cash flow conversion efficiency of Theralase Technologies Inc. from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Theralase Technologies Inc. stock valuation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$1.78 Million
≈ $1.29 Million
CA$-3.29 Million
≈ $-2.38 Million
-1.848x -14.88%
2024-12-31 CA$2.07 Million
≈ $1.50 Million
CA$-3.33 Million
≈ $-2.41 Million
-1.609x +24.73%
2023-12-31 CA$1.91 Million
≈ $1.38 Million
CA$-4.07 Million
≈ $-2.95 Million
-2.137x -28.78%
2022-12-31 CA$3.09 Million
≈ $2.24 Million
CA$-5.13 Million
≈ $-3.71 Million
-1.660x -108.79%
2021-12-31 CA$5.07 Million
≈ $3.67 Million
CA$-4.03 Million
≈ $-2.92 Million
-0.795x -63.83%
2020-12-31 CA$9.16 Million
≈ $6.63 Million
CA$-4.45 Million
≈ $-3.22 Million
-0.485x -2.38%
2019-12-31 CA$13.86 Million
≈ $10.02 Million
CA$-6.57 Million
≈ $-4.75 Million
-0.474x +61.07%
2018-12-31 CA$998.64K
≈ $722.40K
CA$-1.22 Million
≈ $-879.39K
-1.217x +41.54%
2017-12-31 CA$2.05 Million
≈ $1.48 Million
CA$-4.26 Million
≈ $-3.08 Million
-2.082x -142.84%
2016-12-31 CA$5.69 Million
≈ $4.12 Million
CA$-4.88 Million
≈ $-3.53 Million
-0.858x -7.39%
2015-12-31 CA$6.32 Million
≈ $4.57 Million
CA$-5.04 Million
≈ $-3.65 Million
-0.799x +27.19%
2014-12-31 CA$3.31 Million
≈ $2.39 Million
CA$-3.63 Million
≈ $-2.62 Million
-1.097x -111.05%
2013-12-31 CA$1.76 Million
≈ $1.28 Million
CA$-916.67K
≈ $-663.11K
-0.520x -105.54%
2012-12-31 CA$-64.73K
≈ $-46.82K
CA$-606.72K
≈ $-438.89K
9.373x +405.21%
2011-12-31 CA$455.16K
≈ $329.25K
CA$-1.40 Million
≈ $-1.01 Million
-3.071x -663.82%
2010-12-31 CA$2.53 Million
≈ $1.83 Million
CA$-1.02 Million
≈ $-735.94K
-0.402x -3323.44%
2009-12-31 CA$3.49 Million
≈ $2.52 Million
CA$-40.95K
≈ $-29.62K
-0.012x +92.02%
2008-12-31 CA$2.39 Million
≈ $1.73 Million
CA$-351.19K
≈ $-254.05K
-0.147x -41.17%
2007-12-31 CA$3.37 Million
≈ $2.44 Million
CA$-351.49K
≈ $-254.26K
-0.104x -1262.74%
2006-12-31 CA$3.37 Million
≈ $2.44 Million
CA$-25.78K
≈ $-18.65K
-0.008x -130.39%
2005-12-31 CA$3.39 Million
≈ $2.45 Million
CA$85.33K
≈ $61.73K
0.025x +130.40%
2004-12-31 CA$1.05 Million
≈ $762.12K
CA$-87.23K
≈ $-63.10K
-0.083x +82.82%
2003-12-31 CA$399.21K
≈ $288.78K
CA$-192.39K
≈ $-139.17K
-0.482x +13.24%
2002-12-31 CA$87.35K
≈ $63.19K
CA$-48.52K
≈ $-35.10K
-0.555x +7.87%
2001-12-31 CA$137.03K
≈ $99.13K
CA$-82.62K
≈ $-59.76K
-0.603x --

About Theralase Technologies Inc.

V:TLT Canada Medical Devices
Market Cap
$57.75 Million
CA$79.83 Million CAD
Market Cap Rank
#21334 Global
#742 in Canada
Share Price
CA$0.27
Change (1 day)
-5.26%
52-Week Range
CA$0.15 - CA$0.39
All Time High
CA$0.58
About

Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research, development, and commercialization of energy activated small molecules and associated drug formulations in Canada, the United States, and internationally. The company operates in two segments, Drug Division and Device Division. It engages in the research and development of Rutherrin, an injectable form … Read more